Guidance on applications for COVID-19 drug...
Dataset description:
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 22, 2024 |
| Metadata last updated | October 22, 2024 |
| Created | October 22, 2024 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | 1f62fb3a-fc12-4aad-854e-5faeb1960a68 |
| Package id | cf1e0f35-7f81-4579-a326-2cc82606bcf4 |
| Position | 1 |
| State | active |